Updates on contrast-induced nephropathy

Chairpersons: A. Bartorelli, R. Cifkova

Presentations available when logged in:

  • Glycosilated hemoglobin levels and the risk of contrast induced nephropathy in non-diabetic patients undergoing coronary angiography or PCI
  • Admission hyperglycemia and contrast induced nephropathy
  • High dose atorvastatin pre-treatment for preventing contrast-induced nephropathy in patients receiving primary PCI: pre-specified substudy of a pro...
  • Urinary liver-type fatty acid-binding protein (L-FABP) predict contrast-induced nephropathy and persistent renal damage after PCI